Ceapro (CVE:CZO) Stock Price Down 11.8% – What’s Next?

Ceapro Inc. (CVE:CZO) shares dropped 11.8% on Wednesday . The company traded as low as C$0.23 and last traded at C$0.23. Approximately 5,850 shares were traded during trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.

Ceapro Stock Performance

The firm has a market capitalization of C$17.62 million, a price-to-earnings ratio of -3.75 and a beta of 1.38. The company has a 50-day moving average price of C$0.22 and a 200-day moving average price of C$0.23. The company has a quick ratio of 18.88, a current ratio of 8.54 and a debt-to-equity ratio of 8.07.

About Ceapro

Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.